948294-96-0

((R)-1-((S)-2-Amino-3-phenylpropanamido)-3-methylbutyl)boronic Acid is a useful research compound.

Des-pyrazinecarboxaldehyde Bortezomib is the intermediate and impurity for Bortezomib (B675700), which is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.